Abstract: Silage compositions are described herein, as well as methods for their preparation and use. A silage composition may include a fatty acid component comprising at least about 70% saturated fatty acid by weight and a fermented component. The fatty acid component may be present in the silage composition in an amount of at least about 10% by weight of the silage composition.

Abstract: A feed for ruminants may include at least one derivatized fatty acid component such that ingestion of the feed by lactating ruminants may provide for an increase in the amount of milk produced by the ruminant, and/or an increase in the fat content of the milk produced.

Abstract: A feed for ruminants may include at least one fatty acid component covalently linked with a carrier particle such that ingestion of the feed by lactating ruminants may provide for an increase in the amount of milk produced by the ruminant, and/or an increase in the fat content of the milk produced.

Abstract: Disclosed are compounds or pharmaceutically acceptable salts thereof, having the structure of formula I. Also disclosed are methods of preventing and/or treating degenerative disease in a subject, comprising administering to said subject a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions for preventing and/or treating de-generative disease in a subject comprising a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.

Abstract: A novel bioconjugate and a method for delivering the bioconjugate to a cell site is described. In particular, the bioconjugate composition comprises a targeting agent conjugated to a diagnostically or therapeutically effective agent by a metabolizable linker moiety which is cleaved by an exogenous enzyme.